Articles
The Anti-Aging Market Size accounted for USD 195.9 Billion in 2023 and is estimated to achieve a market size of USD 381.2 Billion by 2032 growing at a CAGR of 7.8% from 2024 to 2032.
The anti-aging market has witnessed exponential growth in recent years, with increasing consumer demand for innovative solutions that cater to the desire for youthful, radiant skin and overall vitality. Valued at USD 195.9 billion in 2023, this market is projected to reach USD 381.2 billion by 2032, growing at a robust CAGR of 7.8% from 2024 to 2032. This article explores the competitive landscape, future growth prospects, opportunities, drivers, restraints, leading market players, current trends, and regional insights shaping this dynamic industry. Download Free Anti-Aging Market Sample Report Here: (Including…
The anti-aging market has witnessed exponential growth in recent years, with increasing consumer demand for innovative solutions that cater to the desire for youthful, radiant skin and overall vitality. Valued at USD 195.9 billion in 2023, this market is projected to reach USD 381.2 billion by 2032, growing at a robust CAGR of 7.8% from 2024 to 2032. This article explores the competitive landscape, future growth prospects, opportunities, drivers, restraints, leading market players, current trends, and regional insights shaping this dynamic industry. Download Free Anti-Aging Market Sample Report Here: (Including…
The global Anti-Allergic Drugs Market was valued at US$ 26,234 Million in 2021 and is projected to reach US$ 47,566 Million by 2030, growing at a CAGR of 6.8% from 2022 to 2030. The market is driven by the increasing prevalence of allergic conditions, advancements in drug development, and a growing global focus on addressing chronic illnesses such as allergic rhinitis, asthma, and skin allergies.
Introduction to Allergies and Anti-Allergic Drugs market An allergy is a condition in which the immune system overreacts to substances that are typically harmless, known as allergens. Common allergens include pollen, dust mites, animal dander, and food proteins. When the body encounters these allergens, it triggers an immune response, including the release of histamine, which results in symptoms su…
Introduction to Allergies and Anti-Allergic Drugs market An allergy is a condition in which the immune system overreacts to substances that are typically harmless, known as allergens. Common allergens include pollen, dust mites, animal dander, and food proteins. When the body encounters these allergens, it triggers an immune response, including the release of histamine, which results in symptoms su…
Mesenchymal stem cells market (MSCs) are adult stem cells that hold immense potential for regenerative medicine, especially in the treatment of various chronic diseases, tissue repair, and organ regeneration
Global Mesenchymal Stem Cells Market to Reach US$ 3,319 Million by 2030, Driven by Advancements in Healthcare and Chronic Disease Treatment Mesenchymal stem cells market (MSCs) are adult stem cells that hold immense potential for regenerative medicine, especially in the treatment of various chronic diseases, tissue repair, and organ regeneration. These cells are commonly sourced from bone marrow, adipose tissue, and other organs and can be differentiated into several cell types. This ability to regenerate tissues and organs has positioned MSCs at the forefront of medical research and th…
Global Mesenchymal Stem Cells Market to Reach US$ 3,319 Million by 2030, Driven by Advancements in Healthcare and Chronic Disease Treatment Mesenchymal stem cells market (MSCs) are adult stem cells that hold immense potential for regenerative medicine, especially in the treatment of various chronic diseases, tissue repair, and organ regeneration. These cells are commonly sourced from bone marrow, adipose tissue, and other organs and can be differentiated into several cell types. This ability to regenerate tissues and organs has positioned MSCs at the forefront of medical research and th…
Rising costs, shifting regulations, and the surge of artificial intelligence (AI) have been hot topics in the industry this year and are trends that will continue into 2025. At Velocity, we’re bracing for a year defined by technology-driven efficiencies, an increased emphasis on multisite networks, and lingering regulatory uncertainties.
Rising costs, shifting regulations, and the surge of artificial intelligence (AI) have been hot topics in the industry this year and are trends that will continue into 2025. At Velocity, we’re bracing for a year defined by technology-driven efficiencies, an increased emphasis on multisite networks, and lingering regulatory uncertainties. 1. Rising costs will drive efficiency Research and development cost pressures are ongoing in pharmaceutical development…
Rising costs, shifting regulations, and the surge of artificial intelligence (AI) have been hot topics in the industry this year and are trends that will continue into 2025. At Velocity, we’re bracing for a year defined by technology-driven efficiencies, an increased emphasis on multisite networks, and lingering regulatory uncertainties. 1. Rising costs will drive efficiency Research and development cost pressures are ongoing in pharmaceutical development…
The Modular Chillers Market is poised for significant growth, with the global market size valued at USD 3.9 billion in 2021 and expected to reach USD 6.4 billion by 2030, growing at a CAGR of 5.7% from 2022 to 2030
How Modular Chillers Are Revolutionizing HVAC Systems: A Deep Dive into Energy-Efficient Cooling Solutions Introduction The Modular Chillers Market is poised for significant growth, with the global market size valued at USD 3.9 billion in 2021 and expected to reach USD 6.4 billion by 2030, growing at a CAGR of 5.7% from 2022 to 2030. This surge is attributed to the increasing demand for efficient, customizable, and space-saving HVAC solutions, particularly in urban areas with limited space for traditional chiller systems. Modular chillers, including both modular air-cooled and mo…
How Modular Chillers Are Revolutionizing HVAC Systems: A Deep Dive into Energy-Efficient Cooling Solutions Introduction The Modular Chillers Market is poised for significant growth, with the global market size valued at USD 3.9 billion in 2021 and expected to reach USD 6.4 billion by 2030, growing at a CAGR of 5.7% from 2022 to 2030. This surge is attributed to the increasing demand for efficient, customizable, and space-saving HVAC solutions, particularly in urban areas with limited space for traditional chiller systems. Modular chillers, including both modular air-cooled and mo…
Tissue processing systems market are advanced tools used in the medical and biotechnology industries to prepare and preserve tissue samples for further analysis, diagnosis, and research
Introduction to Tissue Processing Systems Tissue processing systems market are advanced tools used in the medical and biotechnology industries to prepare and preserve tissue samples for further analysis, diagnosis, and research. These systems play a pivotal role in histopathology, molecular biology, and tissue engineering applications, ensuring that tissue samples maintain their integrity and functionality during processing. Over the years, the integration of automated systems and advanced technologies in tissue processing has greatly improved the accuracy, efficiency, and consistency of results. The increas…
Introduction to Tissue Processing Systems Tissue processing systems market are advanced tools used in the medical and biotechnology industries to prepare and preserve tissue samples for further analysis, diagnosis, and research. These systems play a pivotal role in histopathology, molecular biology, and tissue engineering applications, ensuring that tissue samples maintain their integrity and functionality during processing. Over the years, the integration of automated systems and advanced technologies in tissue processing has greatly improved the accuracy, efficiency, and consistency of results. The increas…
The liver cancer diagnostic market is experiencing substantial growth, driven by increasing prevalence rates, advancements in diagnostic technologies, and the ongoing push for early detection methods. This market, valued at USD 8.2 billion in 2023, is projected to reach USD 15.7 billion by 2032, reflecting a robust compound annual growth rate (CAGR) of 7.6% during the forecast period from 2024 to 2032.
Liver cancer, one of the leading causes of cancer-related deaths worldwide, has seen a steady rise in both diagnosis and treatment demand over the past few decades. With the rapid advancements in diagnostic technologies, including imaging techniques, blood tests, and molecular diagnostics, the liver cancer diagnostic market is poised for significant growth. This article delves into the key t…
Liver cancer, one of the leading causes of cancer-related deaths worldwide, has seen a steady rise in both diagnosis and treatment demand over the past few decades. With the rapid advancements in diagnostic technologies, including imaging techniques, blood tests, and molecular diagnostics, the liver cancer diagnostic market is poised for significant growth. This article delves into the key t…
Currently, there are more than 160 PROTAC projects under development worldwide, of which nearly 20 projects are in clinical development. These projects involve a variety of disease targets, including cancer, inflammation, and neurodegenerative diseases.
What Is PROTAC Technology? Proteolytic targeting chimera (PROTAC) is a new type of drug design technology that works by inducing the degradation of target proteins. Unlike conventional small molecules that typically inhibit protein function, PROTACs facilitate the ubiquitination and subsequent degradation of specific proteins. This bifunctional molecule consists of two distinct elements: a ligand that engages a target protein of interest and a second ligand that recruits the E3 ubiquitin ligase, a component of the ubiquitin-proteasome system…
What Is PROTAC Technology? Proteolytic targeting chimera (PROTAC) is a new type of drug design technology that works by inducing the degradation of target proteins. Unlike conventional small molecules that typically inhibit protein function, PROTACs facilitate the ubiquitination and subsequent degradation of specific proteins. This bifunctional molecule consists of two distinct elements: a ligand that engages a target protein of interest and a second ligand that recruits the E3 ubiquitin ligase, a component of the ubiquitin-proteasome system…
16-Dec-2024
Managing vendors across global pharmaceutical supply chains is a significant challenge. AI can help with vendor risk assessments, compliance monitoring, vendor onboarding, and more.
The pharmaceutical industry relies heavily on effective vendor management to ensure product quality, regulatory compliance and timely delivery. However, managing numerous vendors across global supply chains presents significant challenges, from ensuring transparency to mitigating risks. Artificial intelligence (AI) offers transformative solutions that enhance vendor management efficiency, accuracy and decision-making. 1. Vendor Risk Assessment AI can evaluate vendor reliability by analyzing historical data, financial health and compliance records. Machine learning models can identify potential red…
The pharmaceutical industry relies heavily on effective vendor management to ensure product quality, regulatory compliance and timely delivery. However, managing numerous vendors across global supply chains presents significant challenges, from ensuring transparency to mitigating risks. Artificial intelligence (AI) offers transformative solutions that enhance vendor management efficiency, accuracy and decision-making. 1. Vendor Risk Assessment AI can evaluate vendor reliability by analyzing historical data, financial health and compliance records. Machine learning models can identify potential red…
16-Dec-2024
Bladder cancer affects the body’s ability to urinate and can inflict pain. Healthcare professionals understand what causes this disease, though researchers are finding new causes. What are the latest findings on bladder cancer risk factors? Recent studies have discussed emerging causes and the continued importance of established reasons.
Bladder cancer affects the body’s ability to urinate and can inflict pain. Healthcare professionals understand what causes this disease, though researchers are finding new causes. What are the latest findings on bladder cancer risk factors? Recent studies have discussed emerging causes and the continued importance of established reasons. The Latest Developments in Bladder Cancer Risk Factors Discovering new causes of cancer helps medical professionals diag…
Bladder cancer affects the body’s ability to urinate and can inflict pain. Healthcare professionals understand what causes this disease, though researchers are finding new causes. What are the latest findings on bladder cancer risk factors? Recent studies have discussed emerging causes and the continued importance of established reasons. The Latest Developments in Bladder Cancer Risk Factors Discovering new causes of cancer helps medical professionals diag…
For life science startups, the road to innovation often begins with accurate and reliable diagnostic tools. Whether it’s identifying diseases or contributing to groundbreaking research, diagnostic testing for life science startups is an essential component of their success.
For life science startups, the road to innovation often begins with accurate and reliable diagnostic tools. Whether it’s identifying diseases or contributing to groundbreaking research, diagnostic testing for life science startups is an essential component of their success. Types of Diagnostic Testing When it comes to diagnostic testing for life sciences startups, understanding the various types is essential to developing innovative solutions. These are some of the most common categories and their applications. Molecul…
For life science startups, the road to innovation often begins with accurate and reliable diagnostic tools. Whether it’s identifying diseases or contributing to groundbreaking research, diagnostic testing for life science startups is an essential component of their success. Types of Diagnostic Testing When it comes to diagnostic testing for life sciences startups, understanding the various types is essential to developing innovative solutions. These are some of the most common categories and their applications. Molecul…
Hemorrhagic fevers (HF) are some of the most dangerous and complex diseases in the world, posing significant challenges to researchers and healthcare systems. They often progress rapidly and have the potential for devastating outbreaks. With traditional methods struggling to keep up, artificial intelligence (AI) has emerged as a game-changing tool in the fight against HF.
Hemorrhagic fevers (HF) are some of the most dangerous and complex diseases in the world, posing significant challenges to researchers and healthcare systems. They often progress rapidly and have the potential for devastating outbreaks. With traditional methods struggling to keep up, artificial intelligence (AI) has emerged as a game-changing tool in the fight against HF. How researchers are using AI to study hemorrhagic f…
Hemorrhagic fevers (HF) are some of the most dangerous and complex diseases in the world, posing significant challenges to researchers and healthcare systems. They often progress rapidly and have the potential for devastating outbreaks. With traditional methods struggling to keep up, artificial intelligence (AI) has emerged as a game-changing tool in the fight against HF. How researchers are using AI to study hemorrhagic f…
Cancer research is integral to advancing treatment options and developing cures for these diseases. With funding, resources, and collaboration, experts can improve their analysis and help patients. How are ECOG-ACRIN and Caris Life Sciences teaming up to fight cancer? Their recent announcement will benefit clinical trials and molecular profiling.
Cancer research is integral to advancing treatment options and developing cures for these diseases. With funding, resources, and collaboration, experts can improve their analysis and help patients. How are ECOG-ACRIN and Caris Life Sciences teaming up to fight cancer? Their recent announcement will benefit clinical trials and molecular profiling. How ECOG-ACRIN and Caris Life Sciences Are Teaming Up In October 2024, the ECOG-ACRIN Cancer Research G…
Cancer research is integral to advancing treatment options and developing cures for these diseases. With funding, resources, and collaboration, experts can improve their analysis and help patients. How are ECOG-ACRIN and Caris Life Sciences teaming up to fight cancer? Their recent announcement will benefit clinical trials and molecular profiling. How ECOG-ACRIN and Caris Life Sciences Are Teaming Up In October 2024, the ECOG-ACRIN Cancer Research G…
Pascal Degen, Vice President of Global Supply Chain Management at Bachem, explains the challenges faced by the CDMOs in a VUCA world
Pharmaceutical supply chains are becoming increasingly vulnerable to a range of disruptions. From geopolitical upheavals to natural disasters, the unpredictability of the modern world demands innovative strategies for maintaining stability in the face of disruption. Contract Development and Manufacturing Organizations (CDMOs) play a critical role in navigating these challenges by ensuring the consistent production and delivery of life-saving medications. There is a pressing need for CDMOs to address these supply chain challenges in a volatile, uncertain, complex, and ambiguous (VUCA) environment, and to implement strategies for resilience in the face o…
Pharmaceutical supply chains are becoming increasingly vulnerable to a range of disruptions. From geopolitical upheavals to natural disasters, the unpredictability of the modern world demands innovative strategies for maintaining stability in the face of disruption. Contract Development and Manufacturing Organizations (CDMOs) play a critical role in navigating these challenges by ensuring the consistent production and delivery of life-saving medications. There is a pressing need for CDMOs to address these supply chain challenges in a volatile, uncertain, complex, and ambiguous (VUCA) environment, and to implement strategies for resilience in the face o…
The global large bore vascular closure device market is witnessing rapid growth, driven by the increasing demand for effective medical solutions to address large puncture sites in arteries following catheter-based surgeries.
Introduction to the Large Bore Vascular Closure Device Market The global large bore vascular closure device market is a dynamic and rapidly evolving segment of the medical device industry, primarily driven by the increasing prevalence of cardiovascular diseases, advancements in medical technology, and the growing demand for minimally invasive procedures. Large bore vascular closure devices are specialized medical tools used to close large puncture sites in blood vessels, typically resulting from catheter insertions during complex procedures like endovascular surgeries a…
Introduction to the Large Bore Vascular Closure Device Market The global large bore vascular closure device market is a dynamic and rapidly evolving segment of the medical device industry, primarily driven by the increasing prevalence of cardiovascular diseases, advancements in medical technology, and the growing demand for minimally invasive procedures. Large bore vascular closure devices are specialized medical tools used to close large puncture sites in blood vessels, typically resulting from catheter insertions during complex procedures like endovascular surgeries a…
13-Dec-2024
Up to now, the pharma industry’s advances in implementing ISO IDMP product data standards have been patchy. New research has looked more closely at companies’ IDMP readiness, as well as their progress with FAIR data principles and plans to adopt Pistoia Alliance’s IDMP-Ontology. MAIN5’s Michiel Stam discusses the findings.
With renewed momentum around ISO IDMP internationally, MAIN5 recently partnered with Pistoia Alliance and data registry specialist Accurids to determine current progress toward IDMP implementation. The benchmark study[1] also explored companies’ relative maturity in supporting FAIR data principles, geared to making data more Findable, Accessible, Interoperable, and Reusable. These are championed by Pistoia Alliance, whose IDMP-Ontology (IDMP-O) project aims to encourage u…
With renewed momentum around ISO IDMP internationally, MAIN5 recently partnered with Pistoia Alliance and data registry specialist Accurids to determine current progress toward IDMP implementation. The benchmark study[1] also explored companies’ relative maturity in supporting FAIR data principles, geared to making data more Findable, Accessible, Interoperable, and Reusable. These are championed by Pistoia Alliance, whose IDMP-Ontology (IDMP-O) project aims to encourage u…
Especially in recent years, Artificial Intelligence (AI) has emerged as a transformative force across industries, and the pharmaceutical sector is no exception. One of the key areas where AI is having a significant impact is in Quality Assurance (QA). Ensuring the safety, efficacy, and quality of pharmaceutical products is paramount, and AI technologies have the power to revolutionise these processes.
Especially in recent years, Artificial Intelligence (AI) has emerged as a transformative force across industries, and the pharmaceutical sector is no exception. One of the key areas where AI is having a significant impact is in Quality Assurance (QA). Ensuring the safety, efficacy, and quality of pharmaceutical products is paramount, and AI technologies have the power to revolutionise these pr…
Especially in recent years, Artificial Intelligence (AI) has emerged as a transformative force across industries, and the pharmaceutical sector is no exception. One of the key areas where AI is having a significant impact is in Quality Assurance (QA). Ensuring the safety, efficacy, and quality of pharmaceutical products is paramount, and AI technologies have the power to revolutionise these pr…
11-Dec-2024
AI has proven beneficial in the pharmaceutical cold chain by improving the efficacy and safety of temperature-controlled medication. Specifically, AI has helped with real-time temperature monitoring, demand forecasting, quality control, and more.
The health care and pharmaceutical industries have undergone impressive developments in recent years with the rise of artificial intelligence (AI). Cold chains, in particular, have benefited from these new technologies, improving the efficacy and safety of temperature-controlled medication. The Importance of AI in Pharma Cold Chains Cold-chain pharmaceuticals comprise drugs, vaccines, active ingredients and biological substances requiring specialized thermal packaging solutions from production to distribution. The increasing popularity of cel…
The health care and pharmaceutical industries have undergone impressive developments in recent years with the rise of artificial intelligence (AI). Cold chains, in particular, have benefited from these new technologies, improving the efficacy and safety of temperature-controlled medication. The Importance of AI in Pharma Cold Chains Cold-chain pharmaceuticals comprise drugs, vaccines, active ingredients and biological substances requiring specialized thermal packaging solutions from production to distribution. The increasing popularity of cel…
Coulter Partners' recent top global hires for large-cap, mid-cap, and public companies, covered a broad range of disciplines and sectors across Life Sciences, Health and Tech in the second half of 2024.
CEO/ C-suite/ Board Function Focus area Location CEO Medtech (publicly listed) APAC CEO Life science tools (publicly listed) Nordics President Life Sciences Specialty chemicals (large-cap) UK & Ireland Chief Financial Officer Biotech (publicly listed) US Chief Financial Officer Biopharma/ drug delivery (publicly listed) UK & Ireland Chief of Staff Biopharma (publicly listed) Europe Chair Mental health pharma (publicly listed) US/ UK Commercial / Functional / Strategic Leadership …
CEO/ C-suite/ Board Function Focus area Location CEO Medtech (publicly listed) APAC CEO Life science tools (publicly listed) Nordics President Life Sciences Specialty chemicals (large-cap) UK & Ireland Chief Financial Officer Biotech (publicly listed) US Chief Financial Officer Biopharma/ drug delivery (publicly listed) UK & Ireland Chief of Staff Biopharma (publicly listed) Europe Chair Mental health pharma (publicly listed) US/ UK Commercial / Functional / Strategic Leadership …
“The NHS is in a critical condition, but its vital signs are strong” were words captured in Lord Darzi’s recent independent investigation of the National Health Service England . With waiting times for hospital procedures continuing to surge, treatment targets are being missed and this is having a negative impact on patient outcomes – and the health of the nation as a whole.
“The NHS is in a critical condition, but its vital signs are strong” were words captured in Lord Darzi’s recent independent investigation of the National Health Service England[1]. With waiting times for hospital procedures continuing to surge, treatment targets are being missed and this is having a negative impact on patient outcomes – and the health of the nation as a whole. According to figures gathered by the report…
“The NHS is in a critical condition, but its vital signs are strong” were words captured in Lord Darzi’s recent independent investigation of the National Health Service England[1]. With waiting times for hospital procedures continuing to surge, treatment targets are being missed and this is having a negative impact on patient outcomes – and the health of the nation as a whole. According to figures gathered by the report…
